Molecular cloning and expression of a 2-arylpropionyl-coenzyme A epimerase: A key enzyme in the inversion metabolism of ibuprofen

Molecular Pharmacology

Volumn 51, Issue 4, 1997, Pages 576-582

  Reichel, Christine ^a   Brugger, Roland ^a   Bang, Holger ^a   Geisslinger, Gerd ^a,b   Brune, Kay ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Dept Exp Clin Pharmacol Toxicol ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENTARY DNA; EPIMERASE; IBUPROFEN; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PROPIONYL COENZYME A; PROSTAGLANDIN SYNTHASE INHIBITOR;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DRUG METABOLISM; DRUG TRANSFORMATION; ESCHERICHIA COLI; GENE EXPRESSION; IMMUNOBLOTTING; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT;

EID: 0030903324     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.4.576     Document Type: Article

References (38)

1. Kujubu, D. A., B. S. Fletcher, B. C. Varnum, R. W. Lim, and H. R. Herschman TIS 10, a phorbol ester tumor promotor-inducible mRNA from Swiss 3T3 cells encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 266:12866-12872 (1991).
2. Caldwell, J., A. J. Hutt, and S. Fournel-Gigleux. The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochem. Pharmacol. 37:105-114 (1988).
3. Hall, S. D., and O. Xiaotao. The role of coenzyme A in the biotransformation of 2-arylpropionic acids. Chem. Biol. Interact. 90:235-251 (1994).
4. Knadler, M. P., and S. D. Hall. Stereoselective arylpropionyl-CoA thioester formation in vitro. Chirality 2:67-73 (1990).
5. Reichel, C., H. Bang, K. Brune, G. Geisslinger, and S. Menzel. 2-arylpropionyl-CoA epimerase: partial peptide sequences and tissue localization. Biochem. Pharmacol. 50:1803-1806 (1995).
6. Menzel-Soglowek, S., G. Geisslinger, J. Mollenhauer, and K. Brune. Metabolic chiral inversion of 2-arylpropionates in rat H4IIE and human HEP G2 hepatoma cells. Biochem. Pharmacol. 43:1487-1492 (1992).
7. Sanins, S. M., W. J. Adams, D. G. Kaiser, G. W. Halstead, and T. A. Baillie. Studies on the metabolism and chiral inversion of ibuprofen in isolated rat hepatocytes. Drug Metab. Dispos. 18:527-532 (1990).
8. Cox, J. W., S. R. Cox, G. J. VanGiessen, and M. J. Ruwart. Ibuprofen stereoisomer hepatic clearance and distribution in normal and fatty in situ perfused rat liver. J. Pharmacol. Exp. Ther. 232:636-641 (1985).
9. Hall, S. D., M. Hassanzadeh-Khayyat, M. P. Knadler, and P. R. Mayer. Pulmonary inversion of 2-arylpropionic acids: influence of protein binding. Chirality 4:349-352 (1992).
10. Nakamura, Y., and T. Yamaguchi. Stereoselective metabolism of 2-phenylpropionic acid in rat. I. In vitro studies on the stereoselective isomerization and glucuronidation of 2-phenylpropionic acid. Drug Metab. Dispos. 15:529-534 (1987).
11. Tracy, T. S., D. P. Wirthwein, and S. D. Hall. Metabolic inversion of (R)-ibuprofen. Formation of ibuprofenyl-coenzyme A. Drug Metab. Dispos. 21:114-120 (1993).
12. Menzel, S., R. Waibel, K. Brune, and G. Geisslinger. Is the formation of R-ibuprofenyl-adenylate the first stereoselective step of chiral inversion? Biochem. Pharmacol. 48:1056-1058 (1994).
13. Brugger, R., B. García Alía, C. Reichel, S. Menzel, K. Brune, and G. Geisslinger. Isolation and characterization of rat liver microsomal R-ibuprofenyl-CoA synthetase. Biochem. Pharmacol. 52:1007-1013 (1996).
14. Tracy, T. S., and S. D. Hall. Metabolic inversion of (R)-ibuprofen: epimerization and hydrolysis of ibuprofenyl-coenzyme A. Drug Metab. Dispos. 20:322-327 (1992)
15. Chen, C. S., W. R. Shieh, P. H. Lu, S. Harrimann, and S. Y. Chen. Metabolic stereoisomeric inversion of ibuprofen in mammals. Biochim. Biophys. Acta. 1078:411-417 (1991).
16. Shieh, W. R., and C. S. Chen. Purification and characterization of novel "2-arylpropionyl-CoA epimerases" from rat liver cytosol and mitochondria. J. Biol. Chem. 268:3487-3493 (1993).
17. Knihinicki, R. D., R. O. Day, and K. M. Williams. Chiral inversion of 2-arylpropionic acids non-steroidal anti-inflammatory drugs-II. Racemization and hydrolysis of (R)-and (S)-ibuprofen-CoA thioesters. Biochem. Pharmacol. 42:1905-1911 (1991).
18. Fournel, S., and J. Caldwell. The metabolic chiral inversion of 2-phenylpropionic acid in rat, mouse and rabbit. Biochem. Pharmacol. 35:4153-4159 (1986).
19. Maniatis, T., E. F. Fritsch, and J. Sambrock. Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989).
20. Menzel-Soglowek, S., G. Geisslinger, and K. Brune. Stereoselective high-performance liquid chromatographic determination of ketoprofen, ibuprofen and fenoprofen in plasma using a chiral al-acid glycoprotein column. J. Chromatogr. 532:295-303 (1990).
21. Harlow, E., and D. Lane. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1988).
22. Chomczynski, P., and N. Sacchi. Single step method of RNA extraction by guanidinium thiocyanate-phenol-chloroform. Anal. Biochem. 162:156-169 (1987).
23. Kozak, N. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res. 12:857-872 (1984).
24. Proudfoot, N. F., and G. G. Brownlee. 3′ non-coding region sequences in eukaryotic messenger RNA. Nature (Lond.) 263:211-214 (1976).
25. Kennelly, P. J., and E. G. Krebs. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J. Biol. Chem. 266:15555-15558 (1991).
26. Milligan, G., M. Parenti, and A. I. Magee. The dynamic role of palmitoylation in signal transduction. Trends. Biochem. Sci. 20:181-186 (1995).
27. Wilson, R., and P. Wohldman. 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature (Lond.) 368:32-38 (1994).
28. Eichler, K., F. Bourgis, A. Buchet, H. P. Kleber, and M. A. Mandrand-Berthelot. Molecular characterization of the cai operon necessary for carnitine metabolism in Escherichia coli. Mol. Microbiol. 13:775-786 (1994).
29. Jung, H., K. Jung, and H. P. Kleber. Synthesis of L-carnitine by microorganisms and isolated enzymes. Adv. Biochem. Eng. Biotechnol. 50:21-44 (1993).
30. Baillie, T. A., W. J. Adams, D. G. Kaiser, L. S. Olanoff, G. W. Halstead, H. Harpootlian, and G. J. VanGiessen. Mechanistic studies of the metabolic chiral inversion of (R)-ibuprofen in humans. J. Pharmacol. Exp. Ther. 249:517-523 (1989).
31. Schatz, G., and B. Dobberstein. Common principles of protein translocation across membranes. Science (Washington D. C.) 271:1519-1526 (1996).
32. Kyte, J., and R. F. Doolittle. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132 (1982).
33. Hutt, A. J., A. Kooloobandi, and G. W. Hanlon. Microbial metabolism of 2-arylpropionic acids: chiral inversion of ibuprofen and 2-phenylpropionic acid. Chirality 5:596-601 (1993).
34. Suzuki, H., Y. Kawarabayasi, J. Kondo, T. Abe, K. Nishikawa, S. Kimura, T. Hashimoto, and T. Yamamoto. Structure and regulation of rat long-chain acyl-CoA synthetase. J. Biol. Chem. 265:8681-8685 (1990).
35. Fujino, T., and T. Yamamoto. Cloning and functional expression of a novel long-chain acyl-CoA synthetase expressed in brain. J. Biochem. 111:197-203 (1992).
36. Meade, E. A., W. L. Smith, and D. L. DeWitt. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal antiinflammatory drugs. J. Biol. Chem. 268: 6610-6614 (1993).
37. Adams, S. S., P. Bresloff, and C. G. Mason. Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (-)-isomer. J. Pharm. Pharmacol. 28:256-257 (1976).
38. Malmberg, A. B., and T. L. Yaksh. Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J. Neurosci. 15:2768-2776 (1995)